Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity.
about
Immunomodulatory effects of low dose chemotherapy and perspectives of its combination with immunotherapyHuman malignant mesothelioma is recapitulated in immunocompetent BALB/c mice injected with murine AB cells.New roads open up for implementing immunotherapy in mesothelioma.Exploiting synergy: immune-based combinations in the treatment of prostate cancer.Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.The Role of Regulatory T Cells in Mesothelioma.Treatment with cyclophosphamide supported by various dendritic cell-based vaccines induces diversification in CD4⁺ T cell response against MC38 colon carcinomaLong-term intravital imaging of the multicolor-coded tumor microenvironment during combination immunotherapy.Immunotherapy for malignant pleural mesothelioma. Current status and future prospects.Immunotherapy prospects in the treatment of lung cancer and mesothelioma.Immunotherapy for malignant mesothelioma: Reality check.Novel insights into mesothelioma biology and implications for therapy.Heterogeneity in Immune Cell Content in Malignant Pleural Mesothelioma.Prospective trial of metronomic chlorambucil chemotherapy in dogs with naturally occurring cancer
P2860
Q27027093-BEDA08D2-7A22-41C7-BAC8-F384AA909BBBQ27333517-955B4C55-323A-4BAF-98F4-593AD22760BBQ34331993-8B5CB73E-977C-4C5E-A149-1660DD19C94BQ34687216-37490479-A8AA-491A-9C06-1BD04B656955Q35711576-2326FA5B-4318-4C2F-9E8D-9D8BF8DBF8DBQ36101238-3DB3CD12-55E4-4AB3-9BF6-05285AFDB349Q36498103-14C48E61-2D63-4EB2-847E-7C5648CD8FD1Q37520816-AE45A4BB-923D-47B2-8105-66C4CD7E2FFEQ38180749-A24E3F3B-5182-4A7C-9B42-50870BF70C73Q38390104-957867D3-8992-45BF-9F50-B21F13BBBC56Q39351008-09EB93DE-9F90-4C6F-8505-3BAE652B8E28Q39455555-B8FD84A0-6127-4517-BA69-8D61A1C5048CQ55481165-775C9AD7-DE1D-40FF-860C-25751DD0E1C2Q57541220-D4B2142A-6E5C-47C5-933C-0DD70563F421
P2860
Low-dose cyclophosphamide synergizes with dendritic cell-based immunotherapy in antitumor activity.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Low-dose cyclophosphamide syne ...... therapy in antitumor activity.
@ast
Low-dose cyclophosphamide syne ...... therapy in antitumor activity.
@en
type
label
Low-dose cyclophosphamide syne ...... therapy in antitumor activity.
@ast
Low-dose cyclophosphamide syne ...... therapy in antitumor activity.
@en
prefLabel
Low-dose cyclophosphamide syne ...... therapy in antitumor activity.
@ast
Low-dose cyclophosphamide syne ...... therapy in antitumor activity.
@en
P2093
P2860
P356
P1476
Low-dose cyclophosphamide syne ...... therapy in antitumor activity.
@en
P2093
Henk C Hoogsteden
Joachim G J V Aerts
Joost P J J Hegmans
Joris D Veltman
Margaretha E H Lambers
Menno van Nimwegen
Rudi W Hendriks
Sanne de Jong
P2860
P304
P356
10.1155/2010/798467
P577
2010-05-23T00:00:00Z